S ince its initial description in 1996,
1 percutaneous epicardial access (EpiAcc) has played a fundamental role in electrophysiological procedures, mainly to assist in epicardial mapping and ablation. More recently, this approach has been extended to percutaneous atrial appendage suture ligation. Yet, the vast majority of studies using this method have been in patients with no prior cardiac surgical history. Furthermore, those studies which assessed outcomes in patients with prior cardiac surgery had a limited number of patients with prior coronary artery bypass surgery. In the same vein, there are reports suggesting that prior cardiac surgery may prohibit successful EpiAcc, with a 20% success rate in these individuals. 2 Even if access was obtained, catheter movement has been reported as being significantly limited, precluding successful ablation. Conceptually, graft disruption is also a major concern with EpiAcc, mapping, and ablation, but there are no reports of catastrophic bypass disruption and no systematic evaluation of this. The objective of our study was to evaluate the safety of EpiAcc as well as the feasibility and efficacy of epicardial mapping and ablation in all patients with prior cardiac surgery.
EpiAcc Technique
Our approach to EpiAcc has previously been published. 3 Briefly, patients underwent EpiAcc in the electrophysiology laboratory under heavy conscious sedation or general anesthesia. EpiAcc was attempted only after failed endocardial ablation elsewhere or after comprehensive endocardial mapping with no suitable targets during the index procedure. A blunt-tipped epidural needle (Tuohy) was directed from the left para-xiphoid space toward the cardiac silhouette under fluoroscopic guidance in the right anterior oblique/left anterior oblique, anterior-posterior, and lateral views. For anterior puncture, 15° to 30° declination was used during access, whereas for inferior/ posterior access the needle was directed 45° from the horizontal. As the needle penetrated through the fibrous pericardium, a palpable give was appreciated and a puff of contrast demonstrated flow within the pericardial space. A guidewire was advanced into the pericardial space, and right anterior oblique/left anterior oblique imaging used to confirm guidewire position before advancing a sheath over the wire. If significant pericardial adhesions were present as evidenced by difficult catheter maneuverability or layering of contrast, various catheters/wires were used and gently deflected in the opposite direction to coronary grafts, if present (Figures 1 and 2 ). Before ablation, a coronary angiogram was performed, if indicated, to ensure that the ablation catheter tip position was in a safe location away from coronary arteries or grafts (Figure 3 ).
Data Collection
Baseline clinical characteristics, including prior cardiac surgery history, were recorded. Procedural characteristics were collated. The epicardial approach (anterior versus inferior) used was determined by manual review of stored cines recorded at the time of the procedure and procedure note review.
Clinical Follow-Up
All patients underwent transthoracic echocardiography the day after ablation. After hospital dismissal, patients were followed up via telephone interview at 30 days in addition to the follow-up recommended by their primary cardiologist.
Definition of Outcomes
EpiAcc was deemed a success if the pericardial space was entered and catheter manipulation was possible to enable mapping and ablation.
Events and complications were determined and defined as follows:
1. Events: The occurrence of any of the following: pericardial effusion or cardiac tamponade, chronic recurrent pericarditis, phrenic nerve injury, abdominal arterial tree injury, hemothorax, pneumothorax, pleural effusion, coronary vessel injury, liver injury and abdominal injury, intraprocedural loss of EpiAcc, and requirement of blood transfusion within 24 hours. 2. Complications: Any event causing permanent harm or disability, or that required a separate invasive procedure on the completion of the ablation procedure, for example, a repeat pericardiocentesis.
Statistical Analysis
Continuous variables were expressed as mean±SD, whereas categorical variables were expressed as percentages.
Results

Baseline Characteristics
Of 162 patients who underwent EpiAcc, 18 had prior cardiac surgery ( Table 1 ). The median age of the surgical group was 64 years (38-77 years). All were men. Eleven patients had ischemic cardiomyopathy, 3 had nonischemic cardiomyopathy, and 2 had hypertrophic cardiomyopathy. The remaining 2 had no underlying cardiomyopathy but underwent median sternotomy for myocardial bridge unroofing and relief of pericardial tamponade, respectively. Of the 18 patients with previous cardiac surgery ( 
WHAT IS KNOWN
• Percutaneous epicardial access has become a valuable tool during electrophysiological procedures.
• Prior cardiac surgery may prohibit access, limit catheter movement, and preclude successful ablation.
• Although a few studies assessed outcomes in patients with prior cardiac surgery, patient numbers were limited.
• Epicardial access in patients with coronary bypass grafts is frequently avoided because of concern for graft injury.
WHAT THE STUDY ADDS
• Percutaneous epicardial access is feasible in patients with previous cardiac surgery, including coronary bypass grafts.
• To obtain a satisfactory epicardial map, adhesiolysis is frequently required.
• The risk of coronary graft injury is low in experienced centers.
• Constant monitoring and surgical backup are required as life-threatening complications can occur. February 2015
Procedural Characteristics
The procedural characteristics are outlined in Table 3 . Access was successful in 12 of the 18 patients (67%). Of these 18 patients, the inferior approach was used in all but 4 patients (1 patient underwent planned subxiphoid surgical access, 2 underwent successful anterior access, whereas in 1 patient the route of access could not be determined because of insufficient fluoroscopy imaging). Coincidentally, the 2 patients who had anterior access both had previous septal myectomy. In both instances, there was a heavy burden of adhesions anterior to the right ventricle, at the site of previous median sternotomy. However, in both cases, we were able to pass through the adhesions to permit passage of the guidewire into the pericardial space through the EpiAcc needle with subsequent disruption of adhesions. This enabled sufficient epicardial mapping in patient 8 (with subsequent modification of his arrhythmia focus) and perfect entrainment in patient 17 (without epicardial ablation because of proximity of the phrenic nerve and left anterior descending coronary artery; Figure 4 ). Of patients with prior CABG, successful access was attained in 6 (60%). Six patients had unsuccessful access (4 with prior CABG [including 1 with redo sternotomy], 1 aortic valve replacement, and 1 with urgent sternotomy for pericardial tamponade). The average procedural time was 441.6±141.3 minutes. Adhesiolysis was required in 10 patients with the sheath, the access wire, pigtail catheter, or ablation catheter (Figures 1 and 2 ). Intraprocedural coronary angiography was performed in 8 patients (Figure 3 ). There were a total of 45 VTs/PVCs ablated in 18 patients (average, 2.5±1.7 per patient). The underlying arrhythmia mechanism was as follows: re-entry in 38, focal in 6, and triggered activity in 1. The mean cycle length was 463.6±95.9 ms. PVC/ VT morphology and axis are illustrated in Table 4 . Pace mapping was used in 10 patients, entrainment technique in 10, and activation mapping in 13. Substrate modification was performed in 12 patients. Ultimately, 13 patients (72%) underwent endocardial-only ablation, 1 (6%) had epicardialonly ablation, whereas 4 (22%) had both endocardial and epicardial ablation. In 1 patient (patient 17 as outlined above), either proximity of the left phrenic nerve or left main coronary artery/left anterior descending coronary artery junction to the earliest activation site epicardially precluded epicardial ablation and, therefore, endocardial-only ablation was performed. Ultimately, surgical epicardial VT ablation was performed 1 week later during elective surgery for severe, device-related, tricuspid valve regurgitation. In the patient who underwent planned subxiphoid surgical access, ablation was not performed epicardially as an adequate ablation site was not identified. The mean number of ablation burns was 25±13.7; an average total of 1.2±2.9 epicardial and 21.8±13.2 endocardial ablation burns were applied per patient.
Outcomes
As highlighted above, successful EpiAcc was obtained in 12 of the 18 (67%) patients permitting effective epicardial mapping and, if necessary, ablation. Procedural success, in which the clinical VT/PVC was eliminated and remained noninducible, was obtained in 13 patients (72%). At a median follow-up of 250 days (range, 7-1319), 9 (50%) patients remained arrhythmia free. In patients with prior cardiac surgery there were 2 events: 1 had a large pericardial effusion, whereas another formed a small pericardial hematoma that developed intraprocedurally. Both patients recovered without consequence. There were also 2 complications: 1 patient with Marfan syndrome statuspost aortic valve and arch replacement developed pericardial tamponade 2 days postprocedurally and required redo median sternotomy with repair of the diaphragmatic wall of the right ventricle; the other patient developed hemoperitoneum identified on postprocedural day 1 that was managed with blood product support. In patients with coronary grafts, there was no evidence of acute graft disruption. 
Discussion
Percutaneous EpiAcc provides a minimally invasive approach for ablation of VT or PVCs that arise from the epicardial surface of the myocardium. Epicardial substrate is seen more commonly in patients with nonischemic cardiomyopathy, 4 arrhythmogenic right ventricular cardiomyopathy, 5 and less frequently in ischemic cardiomyopathy especially in the setting of prior inferior myocardial infarction. 6, 7 Prior cardiac surgery poses unique obstacles for percutaneous EpiAcc. Increased pericardial fibrosis over the right ventricular free wall inferior to the sternotomy may preclude the identification of a virtual space that can be accessed by the Tuohy needle necessitating an inferiorly directly approach with its inherent risk. 3, 8 Furthermore, in the presence of coronary artery bypass grafts, there is understandable concern for graft disruption, and more care is required during mapping and ablation. This series highlights that percutaneous EpiAcc is feasible in the majority of patients with previous cardiac surgery including CABG with an inferiorly directly approach most frequently used. Sosa et al 9 were the first to report percutaneous EpiAcc in patients with previous cardiac surgery. Although 3 of the 5 patients in their series had prior coronary bypass surgery and were free of complications, areas proximate to the grafts were not mapped because of dense pericardial adhesions. However, we pursued adhesiolysis in 10 patients by careful catheter manipulation (away from coronary grafts, if present) to ensure a maximal mapping area. Interestingly, despite epicardial mapping being used in the majority, few epicardial burns were administered because of lack of suitable ablation targets epicardially. This may have resulted from the preponderance of subendocardial substrate given the number of patients with ischemic cardiomyopathy. Furthermore, although adhesiolysis enabled some epicardial mapping, this may still have been limited and therefore precluded rendition of a full epicardial map leading to failure of identification of suitable epicardial ablation targets. However, despite the fact that epicardial ablation was infrequently performed, the ability to map epicardially likely assisted in a more detailed cardiac map, which led to a reasonable procedural success rate of >70%. Although pericardial fibrosis is most prominent over the right ventricular free wall in those with prior sternotomy, we have observed that the annulus (especially the inferior annulus) is a rare site for adhesions to form. Although fat itself may be inflammatory, it is difficult for pericardial adhesions to form whenever there is no direct contact between the visceral and parietal layers of the pericardium. This may have important clinical implications: if ablation is felt to be required in the inferior or inferolateral annulus, for example, mitral isthmus VT without block after endocardial ablation, EpiAcc can still be used and can be inferior and in the right anterior oblique projection, relatively more annular in entrance (ie, a more parallel course to the sternum while advancing the needle).
In contrast to our findings, a single large series 2 (including 10 patients with prior cardiac surgery) has suggested repeat EpiAcc is feasible in patients with no cardiac surgical history, whereas prior surgery prohibits successful EpiAcc. A series of 8 patients with prior noncoronary cardiac surgery has detailed their results; using blunt dissection, successful epicardial mapping was possible in 7 of 8 patients. 10 However, this was a laborious undertaking, with a mean access time of almost 1 hour (range, 19-125 minutes). Although we did not assess the time it took to obtain EpiAcc, our average procedure time was long (mean, 441.6 minutes), which is in part likely explained by the longer time required to obtain EpiAcc as well as increased case complexity.
Although prior cardiac surgery may be seen as protective against perforation because of increased fibrous tissue, 4 patients did sustain bleeding complications including hemoperitoneum and pericardial tamponade. Periprocedural anticoagulation administration (heparin in 17 patients, bivalirudin in 1 patient) could certainly have contributed to this, yet some fibrotic, scarred tissues can be vascular. A concern of adhesiolysis is disruption of natural bypasses that form between the parietal pericardial vessels and visceral myocardium when breaking through the fibrosis. This is generally expected to be a problem in patients who have occluded coronary vessels, had late revascularization, or revascularization to vessels other than the occluded coronary vessel(s) in whom the bypasses may be more prominent.
Although a concern of EpiAcc in patients with prior coronary bypass surgery, there were no cases of graft disruption in our series. However, coronary angiography was liberally performed for better anatomic definition of the grafts and native vessels.
In patients with substantial pericardial adhesions from prior cardiac surgery and significant pericarditis, direct exposure via surgical means may be useful. Two main types have been described: subxiphoid epicardial window (as was used in one of our patients) and limited anterior thoracotomy. 11, 12 Generally, these procedures will allow access to the region of interest although directly visualized dissection is still required. However, access to other areas may be limited. For example, subxiphoid pericardial window will allow access to the inferior/inferolateral left ventricle, whereas a limited anterior thoracotomy will allow access to the anterior, lateral, and apical regions of the left ventricle. As such, they are likely to be useful if there is a high degree of confidence as to the site of the arrhythmia. Although some may argue for their initial use in patients suspected of having epicardial substrate, it is important to note that these procedures require general anesthesia and are not without risk. In the study by Michowitz et al, 12 3 of 14 patients undergoing surgical access had significant bleeding requiring blood transfusion. We always perform our procedures with surgical backup available. Should percutaneous EpiAcc be unsuccessful, patients will proceed to surgical access if it is still felt that an epicardial substrate exists. Of course, the experience of the proceduralist and the facilities available have to be taken into account; if it is felt that there is a low likelihood of obtaining EpiAcc or no surgical backup is available, then it is probably safest to defer to surgical access as the first step.
More recent data using contrast-enhanced cardiac MRI has shown this imaging modality to be useful in localizing the target ablation site. In the study by Andreu et al, 13 the presence of subepicardial hyperenhancement in the successful ablation segment had a sensitivity of 85% and specificity of 100% in predicting an epicardial origin of the ventricular arrhythmias. As such, preprocedural imaging may preclude the need for empirical EpiAcc and mapping in those who have failed previous endocardial ablation or have a cardiomyopathy that is more likely to be associated with subepicardial substrate. Cardiac MRI preselects patients with likely epicardial substrate; our data show percutaneous access will be feasible in such patients. Certainly, had we used preprocedural cardiac MRI and proceeded with EpiAcc only if an epicardial site was suggested by imaging, we may have had a higher rate of epicardial ablation.
Limitations
Our study is a retrospective analysis that includes patients undergoing percutaneous EpiAcc performed by operators with vast levels of experience in a center with high procedural volume and 24-hour surgical availability. As such, in addition to inherent problems with the study design, results may not be generalizable to other electrophysiology laboratories. Although access was determined by review of stored fluoroscopic images of the initial needle puncture where available, there may be inaccuracies because of sheath repositioning. In addition, pericardioscopy was not performed to determine the site of adhesions. Finally, although we had no cases of graft disruption, this still remains a possibility and likely would become evident had a larger number of patients been analyzed.
Conclusions
Percutaneous EpiAcc is usually feasible in patients with previous cardiac surgery, including coronary bypass grafts, and adhesiolysis is frequently required to obtain a satisfactory epicardial map. Although adequate epicardial mapping was possible in the majority, the rate of epicardial ablation is low in these patients. The risk of coronary graft injury is likely low, and coronary angiography seems to be useful for refining anatomy. Vigilance and surgical backup are required should life-threatening complications occur.
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